News Releases

Select year
Categories

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

Feb 24, 2025 | Corporate | Pipeline | Products

Read more

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

Feb 05, 2025 | Corporate | Pipeline

Read more